Iris Loew-Friedrich is a seasoned biopharmaceutical executive, currently serving as a member of the Supervisory Board at Fresenius Group and as Supervisory Board Chairperson at Evotec. With over 20 years of experience in clinical development, including significant roles at UCB and Aventis, they have overseen the launch of more than 10 new molecular entities in various therapeutic areas. Iris holds a Medical License from Goethe University and a PhD in Biophysics from the Max Planck Institute, and serves as an Adjunct Professor for Internal Medicine. Their commitment to digitalization and innovation in medicine further highlights their leadership in the industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices